Prasol Chemicals Limited · NSE:PRASOLCHEM
Prasol Chemicals — Q1 FY27 Earnings Presentation
30 slides from Prasol Chemicals's earnings presentation, September 2026
Slide 1: Prasol Chemicals Limited Investor Presentation Q1 FY27
Prasol Chemicals Limited Investor Presentation | Q1 FY27 | September 2026
Slide 2: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Prasol Chemicals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any sec
Slide 3: Q1FY27 Performance Highlights
Q1FY27 Performance Highlights
Slide 4: Successful IPO Listing on 16th September 2026
Successful IPO Listing on 16th September 2026 4
Slide 5: Chairman's Message
Chairman’s Message “We are delighted to begin our journey as a listed company on the Indian stock exchanges. For an Indian entrepreneur, this is a dream come true. It is a landmark moment that reflects more than three decades of effort by our team, and it marks the start of an exciting new chapter.
Slide 6: Highest Ever Quarterly Performance
Highest Ever Quarterly Performance Financial performance • Total revenue was Rs 433.6 crores, a growth of 36% YoY basis. Growth came from steady volume growth, a better product mix and higher realisations. • EBITDA was Rs 90.3 crore, up 122% YoY, with a margin of 20.8%. The margins were positively i
Slide 7: Q1FY27 Performance Highlights
Q1FY27 Performance Highlights (INR in crores) Total Revenue Gross Profit 30.0% 37.9% Margin +36% +72% 433.6 164.5 * 319.6 25.0 95.8 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 EBITDA Profit After Tax 12.7% 20.8% 7.6% 14.1% Margin +122% +151% 90.3 * 61.0 * 25.0 40.6 24.3 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 *Due to g
Slide 8: Structured Uptick in Margins Over the Years
Structured Uptick in Margins Over the Years (INR crores) FY11 - FY15 FY16 - FY19 FY20 - FY26 Avg Gross Margin 30% 26.1% 28.5% 30.7% 37.9% Margin Gross Margins 378.7 Avg Gross Margin 26% 288.1 228.7 164.5 COGEN Added in 2019 FY24 FY25 FY26 Q1FY27 Avg Gross Margin 23% Increased capacity under Secondar
Slide 9: Profit & Loss Statement
Profit & Loss Statement Profit and Loss (INR in crores) Q1FY27 Q1FY26 YoY FY26 FY25 YoY Revenue from Operations 433.6 319.6 35.5% 1,232.6 1,012.5 21.7% Cost of Goods Sold 269.1 223.7 853.9 724.4 Gross Margins 164.5 95.8 71.7% 378.7 288.1 31.4% Gross Margin % 37.9% 30.0% 30.7% 28.5% Employee Benefit
Slide 10: Company Overview
Company Overview IPRASOL|
Slide 11: Prominent Manufacturer of Acetone and Phosphorous Specialty Derivatives
Prominent Manufacturer of Acetone and Phosphorous Specialty Derivatives 150+ 98,644 MTPA 65+ 1,600+ 2 Specialty Chemical Installed Capacity Manufacturing Units Export Countries Customers Products (As at FY26) (Khopoli & Mahad) Global Certifications 30+ Years of legacy and experience Responsible Care
Slide 12: 30+ Years of Legacy
30+ Years of Legacy 1992 2010 ₹100 crores 2021 ₹600 crores Incorporation Entered into antioxidants of company and anti-wear industry for lubricants Next Phase of Growth 2022 (2026-2030) 1996 Diversified into 2014 ₹200 crores Launched phosphorous-based Construction products for agro and Chemicals por
Slide 13: Niche Offerings Across Value Chain
Niche Offerings Across Value Chain Multi-chemistry portfolio with 150+ products Key Primary Secondary Tertiary Key Raw Material Serving 20+ End User Industries Platform Derivatives Derivatives Derivatives • Pharmaceutical • Metal Alloys HG, MO, TMC NoI • Agrochemicals • Automotive Acetone IPH Aceton
Slide 14: Diversified by Design across Geographies & End User Industries
Diversified by Design across Geographies & End User Industries Revenue Mix by Geography (FY26) Revenue Mix by Customer (FY26) Revenue Mix by Product (FY26) 73% 27% 19% Domestic Exports Top 10 Customers Contribution 43% Acetone Based Exports — Region-wise not exceeding FY26 Phosphorous Based 12% 7% 5
Slide 15: Strong Manufacturing Capabilities
Strong Manufacturing Capabilities Khopoli Plant Mahad Plant Various chemical reactions/processes Debottleneck and expand production capacities Expand product portfolio and capacities Aldol condensation Hydrogenation Thio Acid synthesis Chelation Chlorination Esterification 1995 78,784 MTPA 2020 19,8
Slide 16: R&D Capabilities
R&D Capabilities Ideas Product Masterlist R&D at a Glance* Technology Masterlist INNOVATION SOURCING No. of Products 40 Products in R&D Pipeline Market Survey PRIORITIZATION R&D Feasibility Financial Feasibility 40 13 New Products Commercialized in 3 Years 37 R&D Member Team (incl. 4 PhDs and 25 Che
Slide 17: Long standing relationships with a diversified customer base & strong global presence
Long standing relationships with a diversified customer base & strong global presence Deep Engagement resulting in improving wallet share 65+ 1,600+ Duration of Relationship with Existing Customers Industry Customer No. of Products Increased from 1 to: Export Countries Customers Performance 15 Years
Slide 18: Recognised for Industry & Customer Excellence
Recognised for Industry & Customer Excellence Awards Rasayan Udyog Chemicals Make in India Partnering Award Responsible Care Hero Award for Industry Excellence Samagam Awards Mr. Nishith Shah Received the award from Safe & Inclusive Workplace Honoured for Industry Excellence Rallis India Limited Rec
Slide 19: Driving Sustainable & Responsible Growth
Driving Sustainable & Responsible Growth Zero Discharge ETP & water recycling supporting Zero Discharge Facility Responsible Business Resource Efficiency Aligns with UN Global Compact Process optimisation, energy principles, TfS standards and ethical efficiency & co-generation. governance practices.
Slide 20: Guided by a Board of Technocrats
Guided by a Board of Technocrats Nishith Rajnikant Shah | Chairman and Whole-time Director G Ramakrishnan | Non-Executive Independent Director Overall strategy and vision Brings experience in building a large specialty chemical company • 36 Years of Experience in the chemical industry • M.com from U
Slide 21: Next Lever of Growth – Embarking on New Phase of Growth
Next Lever of Growth – Embarking on New Phase of Growth* Phase I Expansion Phase I Expansion in Existing Products ~Rs. 250-300 Crores +61% 1,58,844 • Debottlenecking and Process Augmentation at existing Khopoli & 60,000 Mahad Units along with Rs. 50-60 crores in land & infrastructure development • C
Slide 22: …backed by Industry Growth
…backed by Industry Growth Market Size PRASOL – Competitive Edge Acetone Derivative Market Phosphorous Derivatives 33 years of experience $ 25 Bn $ 144 Bn 4% CAGR* 7% CAGR* Long standing relationships CY 2025 CY 2026 with existing customers ₹ 84 Bn ₹ 1,221 Bn 8% CAGR# 10% CAGR# Forward Integrated FY
Slide 23: Historical Financial Highlights
Historical Financial Highlights
Slide 24: Historical Financial Highlights
Historical Financial Highlights Revenue (INR in crores) Gross Margin (INR Crores) EBITDA (INR in crores) PAT (INR in crores) 26.1% 28.5% 30.7% 6.9% 8.7% 11.3% 2.1% 4.3% 6.7% 1,232.6 378.7 139.3 83.1 1,012.5 288.1 876.6 228.7 87.7 43.6 60.5 18.1 FY24 FY25 FY26 FY24 FY25 FY26 FY24 FY25 FY26 FY24 FY25
Slide 25: Historical Profit and Loss Statement
Historical Profit and Loss Statement Particulars (INR in crores) FY26 FY25 FY24 Revenue from Operations 1,232.6 1,012.5 876.6 Cost of Goods Sold 853.9 724.4 647.8 Gross Margins 378.7 288.1 228.7 Gross Margin % 30.7% 28.5% 26.1% Employee Benefit Expenses 50.4 41.7 32.8 Other Expenses 189.0 158.7 135.
Slide 26: Historical Balance Sheet
Historical Balance Sheet Assets (INR in crores) Mar-26 Mar-25 Mar-24 Equity & Liabilities (INR in crores) Mar-26 Mar-25 Mar-24 Non - Current Assets 365.1 350.1 350.8 Total Equity 448.5 367.5 325.8 Property, plant and equipment 311.0 324.4 324.5 Equity share capital 11.6 11.6 11.6 Capital work-in-pro
Slide 27: Historical Cash Flow Statement
Historical Cash Flow Statement Particulars Mar-26 Mar-25 Mar-24 Net Profit Before Tax 111.9 59.3 33.5 Adjustments for Non -Cash Items / Other Investment or Financial Items 36.4 42.0 26.2 Operating profit before working capital changes 148.3 101.3 59.7 Changes in working capital -68.8 -63.8 60.6 Cash
Slide 28: Utilization of IPO Proceeds
Utilization of IPO Proceeds (INR in crores) Amount to be funded Deployed during Fiscal Proposed Fund Allocation from Net Proceeds 2027 Repayment or prepayment of borrowings 60.0 60.0 General corporate purposes 16.4 16.4 Total 76.4 76.4 28
Slide 29: Way Ahead
Way Ahead Ramp up production at Mahad Unit Capacity Expansion in two Phases Debottlenecking existing capacities Way Improving Operational efficiencies Forward To enhance presence in export market Continuous focus on R&D to develop new product lines 29
Slide 30: Thank You
Thank You Innovating Chemistry, Empowering Industries Company Investor Relations Advisor Prasol Chemicals Limited Strategic Growth Advisors Pvt. Ltd. CIN - U99999MH1992PLC065026 CIN - U74140MH2010PTC204285 Ms. Kiran Agarwal, Company Secretary Mr. Shrikant Sangani / Ms. Vaamaa Choksi investorservices